Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | CLK1 | P49759 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23467130 | 0.83 | GPR84 (0.46) | GPR84NR4A2CYP2A6SLC6A4IDO1 | |
| SCHEMBL29764387 | 0.80 | GPR84 (0.64) | GPR84NR4A2CYP2A6SLC6A4IDO1 | |
| SCHEMBL15826494 | 0.80 | GPR84 (0.64) | GPR84NR4A2CYP2A6SLC6A4IDO1 | |
| SCHEMBL28973447 | 0.80 | CYP2A6 (0.60) | GPR84CYP2A6SLC6A4AHRCLK1 | |
| SCHEMBL23487178 | 0.76 | GPR84 (0.46) | GPR84NR4A2CYP2A6SLC6A4IDO1 | |
| SCHEMBL15826665 | 0.75 | GPR84 (0.58) | GPR84NR4A2SLC6A4IDO1GAA | |
| SCHEMBL31332574 | 0.75 | GPR84 (0.58) | GPR84NR4A2SLC6A4IDO1GAA | |
| SCHEMBL28410219 | 0.75 | GPR84 (0.58) | GPR84NR4A2CYP2A6SLC6A4IDO1 | |
| SCHEMBL12093634 | 0.75 | GPR84 (0.58) | GPR84NR4A2SLC6A4IDO1GAA | |
| SCHEMBL154700 | 0.75 | GPR84 (0.58) | GPR84NR4A2SLC6A4IDO1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| WO-2021112478-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-06-10 | — | — | WO | disclosed |
| WO-2021112478-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-06-10 | — | — | WO | disclosed |
| EP-1671136-A4 | A METHOD OF ANALYZING THE TIME-VARYING ELECTRICAL RESPONSE OF A STIMULATED TARGET SUBSTANCE | WORLD ENERGY LABS 2 INC (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1671136-A2 | A METHOD OF ANALYZING THE TIME-VARYING ELECTRICAL RESPONSE OF A STIMULATED TARGET SUBSTANCE | World Energy Labs (2), Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| US-6990422-B2 | Method of analyzing the time-varying electrical response of a stimulated target substance | WORLD ENERGY LABS (2), INC. (US) | 2006-01-24 | — | — | US | disclosed |
| WO-2005029097-A2 | A METHOD OF ANALYZING THE TIME-VARYING ELECTRICAL RESPONSE OF A STIMULATED TARGET SUBSTANCE | WORLD ENERGY LABS (2), INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20040128088-A1 | Method of analyzing the time-varying electrical response of a stimulated target substance | BIOURJA ENERGY SYSTEMS, LLC | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | GPR84 2497/4885NR4A2 1946/4885CYP2A6 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.